Development of a Safe Process for Manufacturing of the Potent Anticancer Agent Melflufen Hydrochloride
Author:
Affiliation:
1. Magle Chemoswed, Agneslundsvägen 27, SE, 212 15 Malmö, Sweden
2. Recipharm OT Chemistry, Virdings Allé 32 B, 754 50 Uppsala, Sweden
Publisher
American Chemical Society (ACS)
Subject
Organic Chemistry,Physical and Theoretical Chemistry
Link
https://pubs.acs.org/doi/pdf/10.1021/acs.oprd.9b00116
Reference15 articles.
1. First-in-human, phase I/IIa clinical study of the peptidase potentiated alkylator melflufen administered every three weeks to patients with advanced solid tumor malignancies
2. The novel alkylating prodrug melflufen (J1) inhibits angiogenesis in vitro and in vivo
3. Structure–Activity Relationship for Alkylating Dipeptide Nitrogen Mustard Derivatives
4. Synthesis of ketobemidone precursorsviaphase-transfer catalysis
5. Improving the Potency of Cancer Immunotherapy by Dual Targeting of IDO1 and DNA
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Binary Catalytic Hydrogen/Deuterium Exchange of Free α‐Amino Acids and Derivatives;Chemistry – A European Journal;2024-09-09
2. Small molecule anticancer drugs approved during 2021–2022: Synthesis and clinical applications;European Journal of Medicinal Chemistry;2024-06
3. Palladium Extraction Following Metal-Catalyzed Reactions: Recent Advances and Applications in the Pharmaceutical Industry;Organic Process Research & Development;2023-09-06
4. A rapid intracellular enrichment of alkylating payload is essential for melphalan flufenamide potency and mechanism of action;Biochemical and Biophysical Research Communications;2023-05
5. Fluorine-containing drugs approved by the FDA in 2021;Chinese Chemical Letters;2023-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3